(Q31042575)

28 June 2017

1 reference

title

Treatment of heparin-induced thrombocytopenia (English)

1 reference

heparin-induced thrombocytopenia

28 June 2017

1 reference

1 reference

William E Dager

1

1 reference

28 June 2017

Richard H White

series ordinal

2

1 reference

28 June 2017

language of work or name

English

0 references

publication date

1 March 2002

1 reference

Annals of Pharmacotherapy

28 June 2017

published in

1 reference

28 June 2017

volume

36

1 reference

28 June 2017

issue

3

1 reference

28 June 2017

page(s)

489-503

1 reference

Newer strategies for the treatment of heparin-induced thrombocytopenia

28 June 2017

cites work

1 reference

A 14-year study of heparin-induced thrombocytopenia

21 January 2018

1 reference

Temporal aspects of heparin-induced thrombocytopenia

21 January 2018

1 reference

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

21 January 2018

1 reference

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

Cross-reactivity study of low molecular weight heparins and heparinoid in heparin-induced thrombocytopenia

21 January 2018

1 reference

Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia

21 January 2018

1 reference

Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies

21 January 2018

1 reference

Heparin induced thrombocytopenia: diagnosis and contemporary antithrombin management

21 January 2018

1 reference

Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia

21 January 2018

1 reference

Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia

21 January 2018

1 reference

Heparin-induced thrombocytopenia: patient profiles and clinical manifestations

21 January 2018

1 reference

Heparin-Induced Thrombocytopenia

21 January 2018

1 reference

Transient global amnesia associated with acute heparin-induced thrombocytopenia

21 January 2018

1 reference

Laboratory testing for heparin-induced thrombocytopenia

21 January 2018

1 reference

Danaparoid in the prevention of thromboembolic complications

21 January 2018

1 reference

Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia

21 January 2018

1 reference

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

21 January 2018

1 reference

Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin.

21 January 2018

1 reference

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

21 January 2018

1 reference

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.

21 January 2018

1 reference

Pharmacological properties of hirudin and its derivatives. Potential clinical advantages over heparin

21 January 2018

1 reference

Kinetic mechanism for the interaction of Hirulog with thrombin.

21 January 2018

1 reference

Clinical outcomes of bivalirudin for ischemic heart disease

21 January 2018

1 reference

Use of Hirulog in the prevention of venous thrombosis after major hip or knee surgery.

21 January 2018

1 reference

The direct thrombin inhibitor melagatran and its oral prodrug H 376/95: intestinal absorption properties, biochemical and pharmacodynamic effects

21 January 2018

1 reference

Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodies

21 January 2018

1 reference

Pentasaccharide Org31540/SR90107A clinical trials update: lessons for practice

21 January 2018

1 reference

The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia

21 January 2018

1 reference

Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia

21 January 2018

1 reference

Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin

21 January 2018

1 reference

Lepirudin dosing in dialysis-dependent renal failure

21 January 2018

1 reference

Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis

21 January 2018

1 reference

Simultaneous monitoring of argatroban and its major metabolite using an HPLC method: potential clinical applications

21 January 2018

1 reference

Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin

21 January 2018

1 reference

Pregnancy complicated by heparin associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172).

21 January 2018

1 reference

Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature

21 January 2018

1 reference

Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium

21 January 2018

1 reference

Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation

21 January 2018

1 reference

Hirudin as anticoagulant for cardiopulmonary bypass: importance of preoperative renal function

21 January 2018

1 reference

Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban

21 January 2018

1 reference

Heparin-induced thrombocytopenia in coronary bypass surgery

21 January 2018

1 reference

Perspectives on the long term management of heparin-induced thrombocytopenia

21 January 2018

1 reference

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

21 January 2018

1 reference

Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK)

21 January 2018

1 reference

Relation between abrupt vessel closure and the anticoagulant response to heparin or bivalirudin during coronary angioplasty.

21 January 2018

1 reference

Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A204

1 reference

28 June 2017

1 reference